Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes - a randomized, single-blinded, cross-over pilot study.

Cardiovasc Diabetol · 2015 · PMC4407869 · PMID 25896352

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

of borderline significancep = 0.06so close (0.05 < p ≤ 0.1)

Liraglutide treatment caused a small increase in CFR, which was of borderline significance (before 2.25 ± 0.31; after 2.43 ± 0.39, p = 0.06).

also in 1,677 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.